US FDA clears diabetes drug for treatment of obesity
Submitted by madhumita on Thu, 2014-12-25 12:56
The US Food and Drug Administration (FDA) has approved diabetes drug Liraglutide (Saxenda, Novo Nordisk) for the treatment of obesity.
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
http://www.asianage.com/india/us-fda-clears-diabetes-drug-treatment-obesity-799
Publication Date:
25/12/2014